Events Partner Content 3rd Annual Bioprocessing Summit Europe Final Weeks to Register for Premier Bioprocessing Event
Events Partner Content Can we target coronavirus RNA with siRNA drugs? NEW: RNAi-Based Therapeutics Summit
Partner Content Partner Content Prescient hires senior members to Advisory PRESCIENT ADVISORY ANNOUNCES RECENT APPOINTMENTS
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.